Icahn School of Medicine at Mount Sinai, CNAG, Karolinska Institutet, and Stanford University will apply 3D spatial multi-omics across neuroscience, immunology, oncology, and tissue atlas research BOSTON — Stellaromics, Inc., the leader in 3D spatial multi-omics, today announced the first commercial placements of its Pyxa® platform, the industry’s first solution for true 3D spatial multi-omics […]
Pioneering initiative will generate data at the frontier of healthcare to help transform early biological signals into new opportunities for prevention, diagnosis and treatment ROCHESTER, Minn. and WALTHAM, Mass. — Mayo Clinic today announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how […]
Enhanced sensitivity enables researchers to measure lower levels of active Proteinase 3 ProAxsis, a commercial protease biomarker-led research company supporting drug development and clinical research through specialist biomarker insights, announces the release of an updated version of their ProteaseTag® Active Proteinase 3 Immunoassay (PA008-RUO). The updated product is a single-use, research use only immunoassay for […]
Milestone continues the progress towards detection of all 20 amino acids by end of 2026BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has demonstrated sequencing with detection of 18 amino acids using a developmental kit run on […]
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results. Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users. MILFORD, Mass. — Waters […]
BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix, partnering closely with the company’s Diagnostics, Scientific, R&D, Regulatory, and […]
Validated on the CellXpress.ai® Automated Cell Culture System, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability, expand scale, and move discoveries toward impact with greater confidence SAN JOSE, Calif. and VANCOUVER, BC – Molecular Devices, a Danaher company and a leading provider of high-performance life science solutions, and STEMCELL […]
10x Genomics, a leader in single-cell and spatial biology, to combine its spatial biology technologies with Lunit’s AI-powered H&E pathology analysis to advance oncology biomarker discovery SEOUL, South Korea — Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 10x Genomics, Inc. (Nasdaq: TXG) will incorporate Lunit’s […]
Tenth SBIR award brings Partillion’s total non-dilutive federal funding to more than $8 million and supports development of Cell-Cell-seq workflows LOS ANGELES — Partillion Bioscience announced a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences (NIGMS) to expand the company’s Cell-Cell-seq workflows. Partillion’s 10th SBIR […]
Submission marks the first time data from the AVA™ Emulation System will be evaluated as part of the FDA qualification process, reinforcing confidence in scalable human-relevant liver models BOSTON — Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, today announced it has submitted its FDA Innovative Science and Technology Approaches for New Drugs (ISTAND) […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
